Dosidal · Switzerland

Zometa 4 mg, Lyophilisat

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:55463 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 55463
atc: M05BA08
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2000-11-28
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: M05BA08
authorisation_number: 55463
form: PULP
holder: Novartis Pharma Schweiz AG
holder_partner_nr: 1006575
it_number: 07.99.0.
name: Zometa 4 mg, Lyophilisat
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
e7lUDjd-kk53PuDYEdJwZSV0mBnO5O8qOS1VD4ZSlmFjusNgjwHyXxUezTBrR4A_TYjrrnFIrWAJDzOhALrZlg
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:55463 · Same medicine in other markets · Dosidal